
FDA investigating PML case in a person treated with fingolimod
The USA Federal Drug Administration (FDA) is investigating a case of progressive multifocal leukoencephalopathy (PML) in a 46

The USA Federal Drug Administration (FDA) is investigating a case of progressive multifocal leukoencephalopathy (PML) in a 46

Multiple Sclerosis Research Australia has welcomed the recent Pharmaceutical Benefits Advisory Committee (PBAC) recommendations for two new oral

ANZgene, the consortium of MS genetics researchers across Australia and New Zealand, supported by MS Research Australia, has

Dr Jeanette Lechner-Scott from the University of Newcastle talks about fatigue and cognition. They are symptoms of Multiple

An economic impact report released today details the cost of multiple sclerosis (MS) to individuals and the national

In one of the largest human genetic studies ever undertaken, scientists have identified the major common genetic variants

Two microRNAs (miRNAs) thought to regulate immune genes are found at lower levels in the blood of those